King Pharmaceuticals pays down entire $28.7 million term loan

By Sara Rosenberg

New York, Nov. 5 - King Pharmaceuticals Inc. repaid its $28.7 million term loan in full in October, according to a 10-Q filed with the Securities and Exchange Commission on Thursday.

Also, the company repaid $18.6 million of its revolving credit facility borrowings during the third quarter.

Including the $18.6 million repayment, during the first nine months of the year, the company repaid $152.8 million of its revolver debt.

King is a Bristol, Tenn.-based pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.